Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No financial specifics were discussed and Bob explicitly said that he doesn't want to start over-promising and possibly under-delivering because of the effect it can have on the stock. The CFO said that they will start issuing guidance when their business is more fully evolved at which time they will be able to make predictions with more certainty.
My take - MMRF is still a startup in a market that hasn't really taken off yet. They are surviving and growing while their competitors are foundering. When EMR fully emerges through both governmental and market actions, MMRF is positioning itself to be a major player. Plus, MMRF has valuable IP.
Nope, power outage slowed me down.
yw, np.
ANNUAL MEETING NOTES
I scrawled down some notes at the meeting - they appear below (I was ready to send them an hour ago but had a power outage in my neighborhood and had to re-type half of the notes). I came away from the meeting very impressed with the MMRF management team and business plan. I believe that MMRF is a very good long-term investment and am happy with my investment.
MMR Global Annual Meeting Notes
- about 25 people in attendance - Bob and Kira Lorsch, CFO, BNY Mellon representative by phone, BOD members, lawyers, accountants, and several shareholders
- All 4 proposals carried with approx 112.6M shares casting votes by proxy
- Business meeting took 15 minutes; Bob adjourned meeting and took questions for 45 minutes
- business is moving forward with Chartis, Kodak, and and other partnerships. MMR needs to hire trainers for the Kodak systems, multi-lingual support people for global call centers. MMR has 70 full-time developers in India, the Midwest, and elsewhere working on products. A number of MMRF's competitors are foundering but MMRF is surviving and growing.
- MyEsafeDepostBox will be re-launched with a new skin and available to Chartis. The Chartis deal effectively locks out all competitors for 3 years giving MMR a huge head-start. MyEsafe is a more robust product than the one offered by Wells Fargo. The Chartis contract is being managed by Doug Helm who also joined the BOD today. He had been hired by Favrille to manage the merger and in lieu of payment took stock in and a job with MMRF. I was very impressed with his knowledge of how to manage a contract with a huge entity such as Chartis. I believe that that contract is in very capable hands.
- MMR currently links to Google Health but Google Health is losing to Microsoft in the marketplace. Google will pull the plug on Google Health and MMR will support it until they do. MMR will link to the Microsoft product.
- Russell Armstrong (somebody from the Favrille past?) has no involvement with MMRF and holds no stock.
- Favrille fought giving up their IP in the merger but MMRF has been successful in acquiring it piece by piece. Bob believes that this IP could add significantly to MMRF's bottom line over the next few years but warned that biotech takes a long time to become profitable. Possible scenarios for MMRF's IP: spin it off into an entity that would benefit MMRF shareholders, license it to other entities, or manufacture vaccines in-house through partners.
- Favrille's tax-loss carry-forward totals between $100M - $200M a portion of which might be available to MMRF.
Very, very good meeting. Bob and team appear to be very committed to success. GLTUA!
I was there and will post my notes later in the day. Very good meeting!
Gotta get lunch now.
NEWS --
DANVILLE, Calif., Jun 15, 2010 (GlobeNewswire via COMTEX) -- S3Investment
Company, Inc. (Pink Sheets:SIVC) and its wholly owned Redwood Capital subsidiary
today commented on the recent graduation of Redwood Capital client Boyuan
Construction Group, Inc. from the TSX Venture Exchange to the Toronto Stock
Exchange (TSX). Boyuan's common shares and debentures now trade on the TSX under
the symbols BOY and BOY.DB, respectively. The graduation became effective at the
market open on June 14, and as a result, Boyuan's common shares and debentures
no longer trade on the TSX Venture Exchange.
Redwood Capital, which assists private Chinese companies in accessing the North
American capital markets by achieving reverse merger and financing transactions,
acted as the Chinese merchant banking advisor for Boyuan Construction Group when
it became listed on Canada's TSX Venture Exchange. As part of its compensation
for its services, Redwood Capital received shares of Boyuan common stock.
On April 15, 2010, Boyuan Construction announced that it had received
conditional approval to graduate from the TSX Venture Exchange and to list its
common shares and debentures on the Toronto Stock Exchange. Boyuan Construction
is a fast-growing construction company in China of commercial, residential and
municipal infrastructure projects. More information on the company can be found
at www.boyuangroup.com or follow Boyuan on Twitter at
www.twitter.com/boyuangroup
"The move to the TSX Exchange is an important milestone for Boyuan Construction
Group and can be shown as an example of further success by a Redwood Capital
client," said S3 Investment Company Chairman and CEO Jim Bickel. "Graduating to
a higher exchange often allows companies greater access to capital and increased
visibility in the public markets, and we congratulate Boyuan Construction on
this move. Since the value of S3 is impacted by the stock holdings on its
consolidated balance sheet, we believe that such a milestone is worth noting for
our shareholders as well."
The value of the stock payments that Redwood Capital receives from its clients'
transactions is reflected in the company's consolidated financial reports posted
at www.otcmarkets.com.
To sign up to receive information by email directly from S3 Investment Company
when new press releases, investor newsletters, SEC filings or other information
is disclosed, please visit http://www.s3investments.com/investors/.
About S3 Investment Company, Inc.
S3 Investment Company, Inc. (http://www.s3investments.com) and its Redwood Group
International subsidiary are focused on facilitating the success of two
subsidiaries operating in the China market. Redwood Capital, Inc. assists
private Chinese companies in accessing the North American capital markets by
utilizing a network of investment banking relationships to achieve reverse
merger transactions. For more information, please visit
http://www.redwo odcapinc.com. Redwood Medical, Inc. assists companies seeking to
import and distribute Western medical technologies and products into the China
market.
Any statements contained herein related to future events are forward-looking
statements and are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Readers are cautioned not to place
undue reliance on forward-looking statements. S3 Investment Company, Inc.
undertakes no obligation to update any such statements to reflect actual events.
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: S3 Investment Company, Inc.
By Staff
CONTACT: CONTACT: S3 Investment Company
Investor Relations
; 888-528-0883
investors@s3investments.com
(C) Copyright 2010 GlobeNewswire, Inc. All rights reserved.
-0-
INDUSTRY KEYWORD: Business Services
SUBJECT CODE: BANKING
CONSTRUCTION
Product Services Announcement
NEWS --
POMPANO BEACH, Fla., Jun 15, 2010 (BUSINESS WIRE) -- Cyclone Power Technologies (Pink Sheets: CYPW) announced today that it has named Bruce Schames as its Chief Financial Officer.
Mr. Schames, a CPA since 1971, has been working with the Company as its outside
accountant since 2008. Since 2001, he has represented both public and private
clients, handling matters of financial statement preparation, SEC audits,
general accounting supervision, operations review, systems development, and tax
planning and compliance reporting. Prior to that, Mr. Schames served as CFO of
East Coast Beverage Corp. (OTCBB: ECBV), and Medcom USA (NASDAQ: EMED), and
Financial Reporting Manager for Dole Fresh Fruit Co.
"We are very pleased to bring Bruce on board," stated Frankie Fruge, COO and
Director of Cyclone. "Bruce has already provided substantial value to our
company and we expect his experience and guidance to be essential as we file our
initial disclosure statements with the Securities and Exchange Commission and
work towards moving our stock to a national exchange."
CORPORATE PROFILE
Cyclone Power Technologies is the developer of the award-winning Cyclone Engine
-- an eco-friendly external combustion engine with the power and versatility to
run everything from portable electric generators and garden equipment to cars,
trucks and locomotives. Invented by company founder and CEO Harry Schoell, the
patented Cyclone Engine is a modern day steam engine, ingeniously designed to
achieve high thermal efficiencies through a compact heat-regenerative process,
and to run on virtually any fuel - including bio-diesels, syngas or solar -
while emitting fewer greenhouse gases and irritating pollutants into the air.
Currently in its late stages of development, the Cyclone Engine was recognized
by Popular Science Magazine as the Invention of the Year for 2008, and was
presented with the Society of Automotive Engineers' AEI Tech Award in 2006 and
2008. Additionally, Cyclone was recently named Environmental Business of the
Year by the Broward County Environmental Protection Department. For more
information, visit www.cyclonepower.com.
Safe Harbor Statement
Certain statements in this news release may contain forward-looking information
within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6
under the Securities Exchange Act of 1934, and are subject to the safe harbor
created by those rules. All statements, other than statements of fact, included
in this release, including, without limitation, statements regarding potential
future plans and objectives of the company, are forward-looking statements that
involve risks and uncertainties. There can be no assurance that such statements
will prove to be accurate and actual results and future events could differ
materially from those anticipated in such statements. The company cautions that
these forward-looking statements are further qualified by other factors. The
company undertakes no obligation to publicly update or revise any statements in
this release, whether as a result of new information, future events or
otherwise.
SOURCE: Cyclone Power Technologies
CONTACT:
Cyclone Power Technologies
Media Contact:
Will Wellons, 407-462-2718
will@redletterpr.com
or
Company Contact:
Frankie Fruge, 954-943-8721
Frankie@cyclonepower.com
Copyright Business Wire 2010
-0-
KEYWORD: United States
North America
Florida
INDUSTRY KEYWORD: Energy
Alternative Energy
Coal
Oil/Gas
Utilities
Other Energy
Technology
Other Technology
Transport
Air
Rail
Trucking
Other Transport
Manufacturing
Automotive Manufacturing
Chemicals/Plastics
Engineering
& nbsp; Other Manufacturing
Natural Resources
Mining/Minerals
Other Natural Resources
Automotive
Environment
Other Science
Construction & Property
&nb sp; Other Construction & Property
General Automotive
Science
SUBJECT CODE: Personnel
Eric be burnin' the Midnight Oil... let's hope it burns brightly for us!
TDGI NEWS (Repeat) --
Jun 12, 2010 (Close-Up Media via COMTEX) -- Target Development Group, the
parent company of entertainment distributor Hannover House, has completed a
preliminary analysis of a corporate opportun ity that would move certain assets
and divisions of Hannover House to a separate, fully-reporting Bulletin Board
entity in consideration of a stock issuance for existing shareholders.
According to officials, subject to a final determination of the stock conversion
and redemption rate, to be specified following the completion of the audit now
underway, the Target Board plans to present the opportunity to TDGI shareholders
this month. The proposed venture, if consummated, would include a significant
amount of new financing for Hannover House operations and releases.
Additionally, the official theatrical trailer for the Hannover House film,
"Twelve" will have its broadcast debut on Entertainment Tonight, airing Friday,
June 4. The trailer and official movie poster art were posted on-line by MTV, a
cross-promotional sponsor for the film. Hannover House has moved the release
date of "Twelve" to July 30. The film had previously been slat ed for release on
July 2, against the similar-skewing-audience blockbuster, "Twilight: Eclipse."
"Our marketing materials for 'Twelve' turned out superbly," said Hannover House
C.E.O., Eric Parkinson. "We've been offered significant placement opportunities
for the trailer to appear on major films throughout late June and the entire
month of July. When you factor in the dramatically less-competitive releases
that we would be up against on the weekend of July 30, it made complete sense
for us to move the release date of the film."
Hannover House will be conducting a press day in New York City on June 21, in
support of the upcoming release of "Twelve." Principal stars from the film will
be interviewed for national television programs, including Entertainment
Tonight, Showbiz Tonight, Access Hollywood, Inside Edition, MTV, B.E.T., E! TV
and more.
((Comments on this story may be sent to newsdesk@closeupmedia.com))
Copyright Close-Up Media, Inc. 2010. All Rights reserved
-0-
INDUSTRY KEYWORD: Entertainment_Close-up
My next post I am sure is related...
NEWS (Repeat) --
Jun 12, 2010 (Close-Up Media via COMTEX) -- Target Development Group, the
parent company of entertainment distributor Hannover House, has completed a
preliminary analysis of a corporate opportun ity that would move certain assets
and divisions of Hannover House to a separate, fully-reporting Bulletin Board
entity in consideration of a stock issuance for existing shareholders.
According to officials, subject to a final determination of the stock conversion
and redemption rate, to be specified following the completion of the audit now
underway, the Target Board plans to present the opportunity to TDGI shareholders
this month. The proposed venture, if consummated, would include a significant
amount of new financing for Hannover House operations and releases.
Additionally, the official theatrical trailer for the Hannover House film,
"Twelve" will have its broadcast debut on Entertainment Tonight, airing Friday,
June 4. The trailer and official movie poster art were posted on-line by MTV, a
cross-promotional sponsor for the film. Hannover House has moved the release
date of "Twelve" to July 30. The film had previously been slat ed for release on
July 2, against the similar-skewing-audience blockbuster, "Twilight: Eclipse."
"Our marketing materials for 'Twelve' turned out superbly," said Hannover House
C.E.O., Eric Parkinson. "We've been offered significant placement opportunities
for the trailer to appear on major films throughout late June and the entire
month of July. When you factor in the dramatically less-competitive releases
that we would be up against on the weekend of July 30, it made complete sense
for us to move the release date of the film."
Hannover House will be conducting a press day in New York City on June 21, in
support of the upcoming release of "Twelve." Principal stars from the film will
be interviewed for national television programs, including Entertainment
Tonight, Showbiz Tonight, Access Hollywood, Inside Edition, MTV, B.E.T., E! TV
and more.
((Comments on this story may be sent to newsdesk@closeupmedia.com))
Copyright Close-Up Media, Inc. 2010. All Rights reserved
-0-
INDUSTRY KEYWORD: Entertainment_Close-up
TDGI NEWS --
NEW YORK, Jun 11, 2010 (BUSINESS WIRE) -- Hannover House, the entertainment
distribution division of Target Development Group, Inc. (Pinksheets: TDGI)
(Other: www.Hannove rHouse.com), has partnered with producer Rohan Ghodsi's
Illusion Film Studios for the production of "Dances With Werewolves," a thriller
by screenwriter David Chirchirillo based on the legendary, supernatural
transformative powers of some Native American Indian warriors. The film will be
produced in 3-D for theatrical release in 2012 through Hannover House, which
will also represent the film for sales and licensing throughout all of North and
South America.
Chad Ferrin ("Someone's Knocking At The Door") will direct the film, with Nicole
Reid and Niklas Larsson sharing producing duties with Ghodsi. Hannover House
principals Eric Parkinson and Fred Shefte are Executive Producers.
"The legend of Native American warriors transforming themselves into enormously
powerful wolves is centuries old," said Hannover House C.E.O., Eric Parkinson.
"But it's a concept that for many audiences was only recently re-introduced
through the successf ul 'Twilight' series of books and films. We think that
screenwriter David Chirchirillo has skillfully crafted a commercial thriller
around this legend, and that Rohan, Chad and the entire production team will
make a terrific movie from this property."
The film will commence principal photography on October 24, 2010 in Michigan,
with full delivery scheduled for September, 2011 and U.S.A. theatrical release
set for February, 2012. Casting is currently underway for principal stars, with
key talent to be announced in July.
Other upcoming theatrical releases from Hannover House include the Joel
Schumacher thriller "Twelve" on July 30, and the Sundance 2010 Film Festival
Audience Award Winner, "HappyThankYouMorePlease" on September 3. Upcoming DVD
and Blu-Ray releases from Hannover House include the action-thriller,
"Boilermaker," the critically-praised drama, "Cook County" and director Abel
Ferarra's "Chelsea on the Rocks," starring Ethan Hawke and the late Dennis
Hopper in one of his last film appearances.
SAFE HARBOR STATEMENT
This press release may contain certain forward-looking statements within the
meaning of Sections 27A & 21E of the amended Securities and Exchange Acts of
1933-34, which are intended to be covered by the safe harbors created thereby.
Although the company believes that the assumptions underlying the
forward-looking statements contained herein are reasonable, there can be no
assurance that these statements included in this press release will prove
accurate.
SOURCE: Hannover House
CONTACT:
Hannover House
Eric Parkinson, 818/481-5277
hannoverhouse@aol.com
Copyright Business Wire 2010
-0-
KEYWORD: United States
; North America
New York
INDUSTRY KEYWORD: Entertainment
Licensing (Entertainment)
Film & Motion Pictures
SUBJECT CODE: Contract/Agreement
OCTI NEWS --
DAVIS, CA, Jun 10, 2010 (MARKETWIRE via COMTEX) -- Octus, Inc. (OTCBB: OCTI), a
leading smart energy efficiency company, today announced the completion of its
acquisition of substantially all of the assets of Quantum Ene rgy Solutions,
Inc., a pioneer developer of energy efficiency projects. Octus announced the
signing of its definitive asset purchase agreement to acquire Quantum on May 18,
2010.
Founded in 1974, Quantum is one of the first energy management companies in the
United States to specialize in energy efficiency. Over the course of their years
with the company, Quantum's principals have executed more than 1,500 energy
projects totaling more than $100 million in value for clients including ARCO,
Bank of America, Blockbuster, Chevron, Delta Airlines, Frito Lay,
Hewlett-Packard, Home Depot, Ikea, Nabisco, Pepsi, Petco, Safeway, Sears,
Siemens, and University of California.
"Quantum is a leader in implementing energy efficiency solutions for commercial,
industrial and institutional building owners and managers," said Chris
Soderquist, Octus CEO. "This expansion catalyzes our mission to significantly
reduce energy expenses and increase cash flow -- immediately and perpetually --
for building owners, managers and occupants. We believe there has never been a
better time to invest in energy efficiency."
Pursuant to the asset purchase agreement, Octus purchased substantially all of
the assets of Quantum for a purchase price subject to certain post-closing
adjustments described in the agreement, and the company agreed to assume certain
liabilities associated with Quantum. Consideration to be paid and liabilities
assumed by Octus in the transaction include: 150,000 shares of common stock
granted to Quantum; assumption of approximately $108,000 in Quantum accounts
payable and credit facilities; assumption of $130,000 in Quantum long-term debt;
and assumption of approximately $50,000 in Quantum accounts receivable. In
addition, Octus entered into a two-year consulting agreement with Quantum
president Jim Collins.
About Octus Octus, Inc. (OTCBB: OCTI) is a smart energy efficiency company that
significantly reduces energy costs for commercial and institutional buildings
through energy-efficient lighting, HVAC and energy management systems. Octus
monetizes the energy savings it creates through three business units: Smart
Energy Technologies, Energy Project Development and the Octus Smart Energy
Platform. Octus and its principals have completed more than 1,500 smart energy
projects. Commercial development is propelled through affiliations with leading
energy institutions, including the California Lighting Technology Center and the
Western Cooling Efficiency Center. Octus was founded in 1983 and is
headquartered in Davis, California.
Forward-Looking Statements This press release contains forward-looking
statements, including, without limitation, statements as to financial
projections and management's beliefs, expectations, goals and opinions. The
company does not undertake to update or revise these s tatements, which are based
on a number of assumptions concerning future conditions that may ultimately
prove to be inaccurate. Future events and their effects on the company may not
be those anticipated, and actual results may differ materially from the results
anticipated in these forward-looking statements. The risks, uncertainties and
factors that could cause or contribute to such material differences are
discussed in the company's annual report on Form 10-K for the year ended
December 31, 2009, filed by the company with the Securities and Exchange
Commission, as updated or supplemented from time to time in subsequent filings.
In addition, this press release contains a number of forward-looking statements
concerning anticipated operations for 2010. The company has only recently become
engaged in the smart energy business and does not have a history of operations
on which future results can be based.
Contact:
< BR>Chris Soderquist
Octus
Email Contact
530/564-0200
http://octusenergy.com
SOURCE: Octus, Inc.
CONTACT: http://www2.marketwire.com/mw/emailprcntct?id=5051A6FBE25805D2
http://octusenergy.com
Copyright 2010 Marketwire, Inc., All rights reserved.
-0-
SUBJECT CODE: Energy and Utilities:Alternative Energy
Environment:Air Pollution Control
Retail:Consumer Interest
&nbs p; Environment:Natural Resource Management
Environment:Hazardous Materials Management
I'm so glad I bailed last week at .035. GLTA.
MMRF NEWS --
LOS ANGELES, CA, Jun 08, 2010 (MARKETWIRE via COMTEX) -- MMR Information
Systems, Inc. (OTCBB: MMRF) (www.mymedicalrecords.com) announced today that it
has enter ed into an agreement with The MichaelBass Group, Inc. to identify
strategic partnerships and acquisition opportunities in healthcare information
technology as part of the Company's plans to expand its line of products and
services.
Robert H. Lorsch, Chairman and CEO of MMR, said, "It's always been our goal to
offer products and services that allow our consumer and physician clients to
take full advantage of technology through strategic partnerships or
acquisitions. The end result is to give MMR the opportunity to sell services to
individuals, families, doctors and hospitals that maximize value to our
shareholders."
The MichaelBass Group tracks and conducts research on over 200 emerging growth
companies in the healthcare information technology sector. MichaelBass conducts
its research on behalf of the Institute for Health Technology Transformation
(www.ihealthtran.com) and others. The Group actively participates in the
program ming of Health Tech Investment Forums
(http://www.ihealthtran.com/healthtechforumnyc.html), with the next one
scheduled to take place September 21, 2010 in New York City.
Last week in New York, MichaelBass working with MMR created a checklist of
criteria to identify revenue generating companies that are additive to MMR
products and services that can be contained inside a personal or electronic
medical record. Examples would include companies that generate lab reports,
provide transcription services or enhanced imaging products and Bluetooth(R)
patient monitoring devices. These companies create content that could be
automatically deposited into a MyMedicalRecords PHR or MyMedicalRecordsMD
account and then be shared with patients through the MMRPatientView portal. The
MichaelBass Group will also seek companies offering EMR products in an effort to
expand MMRPro into a more comprehensive solution inside the physician's office.
Unlike t he Company's competitors, additional benefits will be realized by virtue
of the fact that all this information can then be pushed to the Company's
flagship personal health record reinforcing it as the leading PHR available to
consumers.
"We're excited about the relationship with MMR and particularly working with Bob
Lorsch. Bob has a track record of rolling up companies into one consolidated
entity that in the past had a market cap of over $1 billion dollars," said Greg
Ellis, Senior Research Analyst of the MichaelBass Group. "There are hundreds of
emerging growth companies in health IT that we monitor as part of our ongoing
research strategy and many represent strategic opportunities for MMR. As a part
of this roll-up strategy, there are numerous opportunities for organizations
that are challenged in raising capital during this difficult private equity
market that are logical fits to MMR."
The MichaelBass Group is uniquely posi tioned to serve in an advisory capacity to
MMR with its understanding and extensive transaction research in the healthcare
information technology industry. MichaelBass works extensively with industry
associations, academic institutions, and the leading analysts in healthcare
information technology to understand evolving trends and the landscape of this
rapidly growing sector.
About MMR Information Systems, Inc. MMR Information Systems, Inc., through its
wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR"), provides
secure and easy-to-use online Personal Health Records ("PHRs") and electronic
safe deposit box storage solutions, serving consumers, healthcare professionals,
employers, insurance companies and professional organizations and affinity
groups. MyMedicalRecords enables individuals and families to access their
medical records and other important documents, such as birth certificates,
passports, insurance policies and wills, anytime from anywhere using the
Internet. The MyMedicalRecords Personal Health Record is built on proprietary,
patented technologies to allow documents, images and voicemail messages to be
transmitted and stored in the system using a variety of methods, including fax,
phone, or file upload without relying on any specific electronic medical record
platform to populate a user's account. The Company's professional offering,
MMRPro, is designed to give physicians' offices an easy and cost-effective
solution to digitizing paper-based medical records and sharing them with
patients in real time. MMR is an Independent Software Vendor Partner with Kodak
to deliver an integrated turnkey EMR solution for healthcare professionals. MMR
is also an integrated service provider on Google Health. To learn more about MMR
Information Systems, Inc. and its products, visit www.mymedicalrecords.com and
view the videos at www.mmrvideos.com.
Abo ut MichaelBass Group, Inc. The MichaelBass Group is an investment and
strategic advisory services firm focused on healthcare information technology,
healthcare IT services, healthcare mobility providers, and medical technology
and devices. Our team of research analysts conducts in depth analysis of the
leading companies, trends, and helps our clients to identify transaction
opportunities. Our deep roots in healthcare include working with many public and
private companies as well as industry associations and academic institutions. By
combining technical expertise with invaluable industry insight in healthcare,
The MichaelBass Group provides superior advisory services to every client
engagement. MichaelBass is a research partner & corporate sponsor of the
Institute for Health Technology Transformation. To learn more about The
MichaelBass Group please visit www.michaelbass.com
Forward-Looking Statements Any statements contained in this pr ess release that
refer to future events or other non-historical matters are forward-looking
statements, and some can be identified by the use of words (and their
derivations) such as "need," "possibility," "offer," "development," "if,"
"negotiate," "when," "begun," "believe," "achieve," "will," "estimate,"
"expect," "maintain," "plan," and "continue." MMR Information Systems, Inc.
disclaims any intent or obligation to revise or update any forward-looking
statements. These forward-looking statements are based on MMR Information
Systems, Inc.'s reasonable expectations as of the date of this press release and
are subject to risks and uncertainties that could cause actual results to differ
materially from current expectations. The information discussed in this release
is subject to various risks and uncertainties related to changes in MMR
Information Systems, Inc.'s business prospects, results of operations or
financial condition, governmen t regulation, and such other risks and
uncertainties as detailed from time to time in MMR Information Systems, Inc.'s
public filings with the U.S. Securities and Exchange Commission.
CONTACT:
Bobbie Volman
MMR Information Systems, Inc.
(310) 476-7002, Ext. 2005
bvolman@mmrmail.com
Michael Selsman
Public Communications Co.
(310) 553-5732
ms@publiccommunications.biz
Matthew Raynor
MichaelBass Group, Inc.
(561) 748-6281
matt@michaelbass.com
SOURCE: MMR Information Systems, Inc.
CONTACT: mailto:bvolman@mmrmail.com
mailto:ms@publiccommunications.biz
&n bsp; mailto:matt@michaelbass.com
Copyright 2010 Marketwire, Inc., All rights reserved.
-0-
SUBJECT CODE: Computers and Software:Internet
Medical and Healthcare:Facilities and Providers
Pharmaceuticals and Biotech:Equipment and Supplies
Medical and Healthcare:Healthcare
Medical and Healthcare:Medical Devices
Me dical and Healthcare:Health and Nutrition
CYPW Patent NEWS --
POMPANO BEACH, Fla., Jun 08, 2010 (BUSINESS WIRE) -- Cyclone Power Technologies
(Pink Sheets: CYPW) announced today that the U.S. Patent and Trademark Office
has issued a Notice of Patent Allowance on the centrifugal condenser of the
Company's heat regenerative external combustion engine.
The patented centrifugal condenser, comprised in part of 40 stacked aluminum
plates with over 60 sq.ft. of total surface space, serves to quickly and
efficiently cool the steam exhausted from the engine's cylinders back into
water. The process is capable of lowering temperatures hundreds of degrees (F),
thus allowing the Cyclone Engine to reuse its working fluid (de-ionized water)
in a closed-loop process. Additionally, the cooling air which becomes heated in
the condensing process is regenerated by the Cyclone Engine and used to pre-heat
combustion air in the engine's patented combustion chamber, thereby increasing
thermal efficiencies.
The current patent on the Cyclone Engine is its fifth in the United States. The
Company now has patents on each of the three major component systems of the
engine -- one on its combustion chamber, two on it s mechanical operations
(comprised of pistons, valves, bearings and other sub-components), and now one
on the condensing system. The Company has an overall patent on the total Cyclone
Engine system in the United States and several other nations throughout the
world.
"This new patent provides greater protection for our high-efficiency, clean air
engine system, and added proof of the uniqueness of what we have built," stated
Harry Schoell, Cyclone's CEO and inventor of the engine. "We feel that we have
advanced modern steam technology for motive and small-scale power applications
further than anyone else in the field."
CORPORATE PROFILE
Cyclone Power Technologies is the developer of the award-winning Cyclone Engine
-- an eco-friendly external combustion engine with the power and versatility to
run everything from portable electric generators and garden equipment to cars,
trucks and locomotives. Invented by company founder a nd CEO Harry Schoell, the
patented Cyclone Engine is a modern day steam engine, ingeniously designed to
achieve high thermal efficiencies through a compact heat-regenerative process,
and to run on virtually any fuel - including bio-diesels, syngas or solar -
while emitting fewer greenhouse gases and irritating pollutants into the air.
Currently in its late stages of development, the Cyclone Engine was recognized
by Popular Science Magazine as the Invention of the Year for 2008, and was
presented with the Society of Automotive Engineers' AEI Tech Award in 2006 and
2008. Additionally, Cyclone was recently named Environmental Business of the
Year by the Broward County Environmental Protection Department. For more
information, visit www.cyclonepower.com.
Safe Harbor Statement
Certain statements in this news release may contain forward-looking information
within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6under the Securities Exchange Act of 1934, and are subject to the safe harbor
created by those rules. All statements, other than statements of fact, included
in this release, including, without limitation, statements regarding potential
future plans and objectives of the company, are forward-looking statements that
involve risks and uncertainties. There can be no assurance that such statements
will prove to be accurate and actual results and future events could differ
materially from those anticipated in such statements. The company cautions that
these forward-looking statements are further qualified by other factors. The
company undertakes no obligation to publicly update or revise any statements in
this release, whether as a result of new information, future events or
otherwise.
SOURCE: Cyclone Power Technologies
CONTACT:
Cyclone Power Technologies
Media Contact
Will Wellons, 407-462-2718
will@redletterpr.com
Company Contact:
Frankie Fruge, 954-943-8721
Frankie@cyclonepower.com
Copyright Business Wire 2010
-0-
KEYWORD: United States
North America
Florida
INDUSTRY KEYWORD: Energy
Alternative Energy
Other Energy
Manufacturing
Engineering
Other Manufacturing
Environment
Research
Other Science
Science
I don't know. I got out with a small profit back in March.
Thank you very much, Kat, for your excellent report on Cyclone's progress and plans. "[R]ight place..right time", indeed. I love the 30 - 35% efficiency figures. Excellent prospects for the future.
I am sorry that you feel the need to step down as assistant mod. You have provided great service to all of us on this board during your tenure. I understand and support your decision, however.
CYPW, long and strong.
NEWS --
May 27, 2010 (Close-Up Media via COMTEX) -- Cyclone Power Technologies
announced an informational meeting for its shareholders to be held at the
Company's facility located in Pompano Beach, Fla., at 9 a.m. (EDT) on Friday,
May 28.
In a release on May 24, the company noted that the event is open only to
shareholders of the Company as of the record date of April 28, who have
previously received notification of this event by mail or email.
Reservations are required, therefore, please email accounting@cyclonepower.com
or call Branddi at (954) 943-8721 to reserve your seat.
Cyclone Power Technologies is the developer of the Cyclone Engine -- an
eco-friendly external combustion engine with the power and versatility to run
everything from portable electric generators and garden equipment to cars,
trucks, and locomotives.
More information:
www.cyclonepower.com
((Comments on this story may be sent to newsdesk@closeupmedia.com))
Copyright Close-Up Media, Inc. 2010. All Rights reserved
-0-
INDUSTRY KEYWORD: Manufacturing_Close-up
I'm looking for a gradual upward climb for Racing Dreams driven by word-of-mouth by kids and their families. I wouldn't expect that Mondays are going to be big days for Racing Dreams unless schools are on break.
MMRF NEWS --
LOS ANGELES, CA, May 25, 2010 (MARKETWIRE via COMTEX) -- MMR Information
Systems, Inc. (OTCBB: MMRF) (www.mymedicalrecords .com) announced today that Fred
Middleton, Managing Director of Sanderling Ventures, and Ivor Royston, M.D.,
Founding Managing Member of Forward Ventures and a co-founder of IDEC
Pharmaceuticals (now Biogen Idec), have joined MMR's Board of Advisors in order
to advise Chairman and CEO Robert H. Lorsch on the strategy for maximizing the
value of the Company's biotech assets for the benefit of MMR's shareholders.
According to Lorsch, "Sanderling and Forward Ventures together previously
represented the largest investors in Favrille, Inc., the predecessor public
company to MMR, which raised more than $150 million from investors to fund its
clinical efforts to develop a cancer vaccine to treat lymphomas. Both men
previously served on the Favrille board and are pioneers in the biotechnology
and biomedical industries. They bring MMR a unique knowledge and understanding
of MMR's post merger portfolio of biotech assets. I am delighted that Fred and
Ivor have agreed to assist us in advising the Company on how to maximize the
value of its biotech assets, which include our anti-CD20 monoclonal antibodies
as well as data, tissue samples and other technologies from the Company's
Specifid vaccine trials and manufacturing processes."
Earlier this month Dendreon's Provenge prostate cancer vaccine received approval
from the FDA. The vaccine uses the body's own immune system to target and attack
prostate cancer cells. Favrille spent in excess of $200 million on its Specifid
vaccine before trials were ended in 2008. The Favrille vaccine under development
was made from the idiotype protein from a patient's own tumor cells. Given the
recent Dendreon approvals, the Company believes its data, samples and technology
may offer value in strategic relationships with universities, biotech companies
and licensees who might utilize these assets in the development of similar
cancer fighting vac cines and therapies.
Mr. Middleton has been a Managing Director at Sanderling Ventures since 1987. He
has served as an investor, management team member and director in over 25 new
biomedical ventures built in Sanderling's venture investment portfolios. Mr.
Middleton also previously served as the Founding CFO of Genentech, Inc., and in
various capacities, including Vice President of Finance, Administration,
Corporate Development, Chief Financial Officer, and as President of Genentech
Development Corporation. Mr. Middleton holds an M.B.A. with distinction from
Harvard University and a B.S. degree in Chemistry from the Massachusetts
Institute of Technology.
Dr. Royston, both a scientist and entrepreneur-financier, is a recognized leader
in cancer research and the founding father of San Diego's biotech industry. In
1978, he co-founded Hybritech, Inc., one of the first companies to commercialize
monoclonal antibodies and the first to market a prostate-specific antigen (PSA)
test for prostate cancer. Following the sale of Hybritech, Dr. Royston formed
IDEC Pharmaceuticals (now Biogen Idec), which discovered Rituxan(R) to treat
Non-Hodgkin's Lymphoma and is the best-selling cancer drug worldwide. From
1978-1990, Dr. Royston was on the faculty of the medical school and cancer
center at the University of California, San Diego. From 1990-2000, he served as
the founding President and CEO of the non-profit Sidney Kimmel Cancer Center.
Dr. Royston received the San Diego Entrepreneur of the Year Award in 1994. In
1997, President Clinton appointed him to a six-year term on the National Cancer
Advisory Board. In 2006, Dr. Royston was inducted into San Diego's CONNECT
Entrepreneur Hall of Fame. He earned his B.A. and M.D. degrees from Johns
Hopkins University and completed post-doctoral training in internal medicine and
medical oncology at Stanford University.
Although MMR will continue to maximize the value of its biotech assets to its
shareholders, the Company remains focused on its primary business, which is
specifically the development and distribution of the MyMedicalRecords Personal
Health Record (www.MyMedicalRecords.com) and MMRPro, an end-to-end document
management solution for physicians which features an integrated patient portal
(www.MyMedicalRecordsMD.com), and other related solutions in Health IT based on
the Company's patented technologies.
About MMR Information Systems, Inc.
MMR Information Systems, Inc., through its wholly-owned operating subsidiary,
MyMedicalRecords, Inc. ("MMR"), provides secure and easy-to-use online Personal
Health Records ("PHRs") and electronic safe deposit box storage solutions,
serving consumers, healthcare professionals, employers, insurance companies,
unions and professional organizations and affinity groups. MyMedicalRecords
enables individuals and families to access their medical records and other
important documents, such as birth certificates, passports, insurance policies
and wills, anytime from anywhere using the Internet. The MyMedicalRecords
Personal Health Record is built on proprietary, patented technologies to allow
documents, images and voicemail messages to be transmitted and stored in the
system using a variety of methods, including fax, phone, or file upload without
relying on any specific electronic medical record platform to populate a user's
account. The Company's professional offering, MMRPro, is designed to give
physicians' offices an easy and cost-effective solution to digitizing
paper-based medical records and sharing them with patients in real time. MMR is
an Independent Software Vendor Partner with Kodak to deliver an integrated
turnkey EMR solution for healthcare professionals. MMR is also an integrated
service provider on Google Health. To learn more about M MR Information Systems,
Inc. and its products, visit www.mymedicalrecords.com and view the videos at
www.mmrvideos.com.
Forward-Looking Statements
Any statements contained in this press release that refer to future events or
other non-historical matters are forward-looking statements, and some can be
identified by the use of words (and their derivations) such as "need,"
"possibility," "offer," "development," "if," "negotiate," "when," "begun,"
"believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and
"continue." Such statements include, but are not limited to, statements
regarding the Company's assets including but not limited to its primary Health
IT businesses, data from vaccine and clinical trials, and anti-CD20 antibody
assets. Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause actual results to be materially
different from historical results o r from any results expressed or implied by
such forward-looking statements. These factors include, but are not limited to,
risks and uncertainties related to the development and approval of
biotechnology/biopharmaceutical product candidates and Health IT products and
additional risks discussed in the Company's filings with the Securities and
Exchange Commission. All subsequent written and oral forward-looking statements
attributable to the Company (or any person acting on the Company's behalf) are
qualified by the cautionary statements in this notice. MMR Information Systems,
Inc. is providing this information as of the date of this release and, except as
required by law, does not undertake any obligation to update any forward-looking
statements contained in this release as a result of new information, future
events or otherwise.
CONTACT:
Bobbie Volman
MMR Information Systems, Inc.
(310) 476-7002, Ext. 2005
bvolman@mmrmail.com
Michael Selsman
Public Communications Co.
(310) 553-5732
ms@publiccommunications.biz
SOURCE: MMR Information Systems, Inc.
CONTACT: mailto:bvolman@mmrmail.com
mailto:ms@publiccommunications.biz
Copyright 2010 Marketwire, Inc., All rights reserved.
-0-
SUBJECT CODE: Computers and Software:Internet
Professional Services:Purchasing
Computers and Software:Peripherals
&nbs p; Computers and Software:Software
Medical and Healthcare:Alternative
Medical and Healthcare:Facilities and Providers
Medical and Healthcare:Health and Nutrition
Medical and Healthcare:Healthcare
Medical and Healthcare:Surgery and Treatments
&nbs p; Pharmaceuticals and Biotech:Biotech
Pharmaceuticals and Biotech:Drugs
Pharmaceuticals and Biotech:Equipment and Supplies
Pharmaceuticals and Biotech:Trials
Professional Services:Other Professional Services
Computers and Software:Networking
MMRF NEWS --
LOS ANGELES, CA, May 25, 2010 (MARKETWIRE via COMTEX) -- MMR Information
Systems, Inc. (OTCBB: MMRF) (www.mymedicalrecords .com) announced today that Fred
Middleton, Managing Director of Sanderling Ventures, and Ivor Royston, M.D.,
Founding Managing Member of Forward Ventures and a co-founder of IDEC
Pharmaceuticals (now Biogen Idec), have joined MMR's Board of Advisors in order
to advise Chairman and CEO Robert H. Lorsch on the strategy for maximizing the
value of the Company's biotech assets for the benefit of MMR's shareholders.
According to Lorsch, "Sanderling and Forward Ventures together previously
represented the largest investors in Favrille, Inc., the predecessor public
company to MMR, which raised more than $150 million from investors to fund its
clinical efforts to develop a cancer vaccine to treat lymphomas. Both men
previously served on the Favrille board and are pioneers in the biotechnology
and biomedical industries. They bring MMR a unique knowledge and understanding
of MMR's post merger portfolio of biotech assets. I am delighted that Fred and
Ivor have agreed to assist us in advising the Company on how to maximize the
value of its biotech assets, which include our anti-CD20 monoclonal antibodies
as well as data, tissue samples and other technologies from the Company's
Specifid vaccine trials and manufacturing processes."
Earlier this month Dendreon's Provenge prostate cancer vaccine received approval
from the FDA. The vaccine uses the body's own immune system to target and attack
prostate cancer cells. Favrille spent in excess of $200 million on its Specifid
vaccine before trials were ended in 2008. The Favrille vaccine under development
was made from the idiotype protein from a patient's own tumor cells. Given the
recent Dendreon approvals, the Company believes its data, samples and technology
may offer value in strategic relationships with universities, biotech companies
and licensees who might utilize these assets in the development of similar
cancer fighting vac cines and therapies.
Mr. Middleton has been a Managing Director at Sanderling Ventures since 1987. He
has served as an investor, management team member and director in over 25 new
biomedical ventures built in Sanderling's venture investment portfolios. Mr.
Middleton also previously served as the Founding CFO of Genentech, Inc., and in
various capacities, including Vice President of Finance, Administration,
Corporate Development, Chief Financial Officer, and as President of Genentech
Development Corporation. Mr. Middleton holds an M.B.A. with distinction from
Harvard University and a B.S. degree in Chemistry from the Massachusetts
Institute of Technology.
Dr. Royston, both a scientist and entrepreneur-financier, is a recognized leader
in cancer research and the founding father of San Diego's biotech industry. In
1978, he co-founded Hybritech, Inc., one of the first companies to commercialize
monoclonal antibodies and the first to market a prostate-specific antigen (PSA)
test for prostate cancer. Following the sale of Hybritech, Dr. Royston formed
IDEC Pharmaceuticals (now Biogen Idec), which discovered Rituxan(R) to treat
Non-Hodgkin's Lymphoma and is the best-selling cancer drug worldwide. From
1978-1990, Dr. Royston was on the faculty of the medical school and cancer
center at the University of California, San Diego. From 1990-2000, he served as
the founding President and CEO of the non-profit Sidney Kimmel Cancer Center.
Dr. Royston received the San Diego Entrepreneur of the Year Award in 1994. In
1997, President Clinton appointed him to a six-year term on the National Cancer
Advisory Board. In 2006, Dr. Royston was inducted into San Diego's CONNECT
Entrepreneur Hall of Fame. He earned his B.A. and M.D. degrees from Johns
Hopkins University and completed post-doctoral training in internal medicine and
medical oncology at Stanford University.
Although MMR will continue to maximize the value of its biotech assets to its
shareholders, the Company remains focused on its primary business, which is
specifically the development and distribution of the MyMedicalRecords Personal
Health Record (www.MyMedicalRecords.com) and MMRPro, an end-to-end document
management solution for physicians which features an integrated patient portal
(www.MyMedicalRecordsMD.com), and other related solutions in Health IT based on
the Company's patented technologies.
About MMR Information Systems, Inc.
MMR Information Systems, Inc., through its wholly-owned operating subsidiary,
MyMedicalRecords, Inc. ("MMR"), provides secure and easy-to-use online Personal
Health Records ("PHRs") and electronic safe deposit box storage solutions,
serving consumers, healthcare professionals, employers, insurance companies,
unions and professional organizations and affinity groups. MyMedicalRecords
enables individuals and families to access their medical records and other
important documents, such as birth certificates, passports, insurance policies
and wills, anytime from anywhere using the Internet. The MyMedicalRecords
Personal Health Record is built on proprietary, patented technologies to allow
documents, images and voicemail messages to be transmitted and stored in the
system using a variety of methods, including fax, phone, or file upload without
relying on any specific electronic medical record platform to populate a user's
account. The Company's professional offering, MMRPro, is designed to give
physicians' offices an easy and cost-effective solution to digitizing
paper-based medical records and sharing them with patients in real time. MMR is
an Independent Software Vendor Partner with Kodak to deliver an integrated
turnkey EMR solution for healthcare professionals. MMR is also an integrated
service provider on Google Health. To learn more about M MR Information Systems,
Inc. and its products, visit www.mymedicalrecords.com and view the videos at
www.mmrvideos.com.
Forward-Looking Statements
Any statements contained in this press release that refer to future events or
other non-historical matters are forward-looking statements, and some can be
identified by the use of words (and their derivations) such as "need,"
"possibility," "offer," "development," "if," "negotiate," "when," "begun,"
"believe," "achieve," "will," "estimate," "expect," "maintain," "plan," and
"continue." Such statements include, but are not limited to, statements
regarding the Company's assets including but not limited to its primary Health
IT businesses, data from vaccine and clinical trials, and anti-CD20 antibody
assets. Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause actual results to be materially
different from historical results o r from any results expressed or implied by
such forward-looking statements. These factors include, but are not limited to,
risks and uncertainties related to the development and approval of
biotechnology/biopharmaceutical product candidates and Health IT products and
additional risks discussed in the Company's filings with the Securities and
Exchange Commission. All subsequent written and oral forward-looking statements
attributable to the Company (or any person acting on the Company's behalf) are
qualified by the cautionary statements in this notice. MMR Information Systems,
Inc. is providing this information as of the date of this release and, except as
required by law, does not undertake any obligation to update any forward-looking
statements contained in this release as a result of new information, future
events or otherwise.
CONTACT:
Bobbie Volman
MMR Information Systems, Inc.
(310) 476-7002, Ext. 2005
bvolman@mmrmail.com
Michael Selsman
Public Communications Co.
(310) 553-5732
ms@publiccommunications.biz
SOURCE: MMR Information Systems, Inc.
CONTACT: mailto:bvolman@mmrmail.com
mailto:ms@publiccommunications.biz
Copyright 2010 Marketwire, Inc., All rights reserved.
-0-
SUBJECT CODE: Computers and Software:Internet
Professional Services:Purchasing
Computers and Software:Peripherals
&nbs p; Computers and Software:Software
Medical and Healthcare:Alternative
Medical and Healthcare:Facilities and Providers
Medical and Healthcare:Health and Nutrition
Medical and Healthcare:Healthcare
Medical and Healthcare:Surgery and Treatments
&nbs p; Pharmaceuticals and Biotech:Biotech
Pharmaceuticals and Biotech:Drugs
Pharmaceuticals and Biotech:Equipment and Supplies
Pharmaceuticals and Biotech:Trials
Professional Services:Other Professional Services
Computers and Software:Networking
OCTI NEWS --
LINCOLN, Neb., May 25, 2010 (GlobeNewswire via COMTEX) -- A research report has
been issued by Market Advisors, Inc. "Fundamental Analysis for Today's
Investments" on Octus Energy, Inc. (OTCBB:OCTI). To view the report , please go
to our web site at www.marketadvisorsinc.com
The report details some of the significant achievements by this "green energy"
company which have been capped in recent press releases on May 17, 2010 and
again on May 20, 2010.
An excerpt from the report states, "It appears that with their current product
line, definitive purchase agreement of Quantum Energy Solutions and the powerful
list of clients that come with the purchase, OTCI is poised to break out from
its current price of $0.11 per share". Market Advisors issues a speculative buy
on OCTI with an intermediate target price of $0.38.
About Market Advisors, Inc.
Officers of Market Advisors, Inc. have been in business since 1983 and have
provided stock market research for their clients since 1985. Company officials
have often been quoted in a wide array of financial publications such as the
Wall Street Journal, Investors Business Daily, Barron's, Forbes Ma gazine and The
Dick Davis Digest to name a few.
The information and opinions in this analyst report were prepared by Market
Advisors, Inc. (located in Nebraska) who does receive fees for services
including preparation of this report. For this research report, officers of
Market Advisors, Inc. received $2,250.00 from Treasure Coast Health Associates,
a third party. This is not an offer to buy or sell securities nor should this
report be construed as investment advice. Information or statements are subject
to numerous risks and uncertainties that cause such statements not to prove
accurate. Market Advisors, Inc. does not disseminate, nor is it liable for the
dissemination by any third party of this analyst report.
Octus Energy, Inc:
Octus Energy, Inc. is a smart energy management company that reduces energy
costs for commercial and institutional buildings by 50% or more through
energy-efficient lighting, HVAC and energy man agement systems.
For further corporate information from Octus Energy, Inc., please visit:
www.octusenergy.com
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: Market Advisors, Inc.
By Staff
CONTACT: CONTACT: Octus Energy, Inc
(530-564-0200)
Market Advisors
(308) 385-4991
(C) Copyright 2010 GlobeNewswire, Inc. All rights reserved.
-0-
INDUSTRY KEYW ORD: Advertising
SUBJECT CODE: ENERGY
Research Analysis and Reports
TDGI - The Rock was just on in the 8:49 AM PT segment of Good Day LA on KTLA Ch 11 in Los Angeles talking about Racing Dreams. Nice!
Hopefully, they'll archive the segment at:
http://www.myfoxla.com/subindex/good_day_la
;) I saw that. Strange, but then again what hasn't been strange with this puppy?
OCTI NEWS --
DAVIS, CA, May 20, 2010 (MARKETWIRE via COMTEX) -- Octus, Inc. (OTCBB: OCTI), a
leading smart energy efficiency company, today announced the launch of
SmartEnergyWorks, an energy e fficiency information forum and resource network
for commercial real estate property owners, managers and investors.
SmartEnegyWorks can be accessed via the Octus Website, http://octusenergy.com,
or directly: http://smartenergyworks.blogspot.com/.
"The premise of SmartEnergyWorks is simple: It enables Octus to share pragmatic,
ready-to-implement energy-savings measures and project financing strategies, and
engage in a conversation with property owners, managers and investors who are
interested in reducing their energy costs," said Octus CEO Chris Soderquist.
Recent SmartEnergyWorks posts include:
-- $50 billion reasons energy efficiency works
-- Energy Efficiency and Real Estate: Opportunities for Investors
-- Five barriers to energy efficiency savings: What we can learn from
Google and GE
-- California cities and counties set the PACE in financing energy
efficiency projects
-- As Energy Efficiency Booms, Buildings Get a Brain
-- Key Lessons: Energy Efficiency Retrofits
-- Building Star: The latest star for energy efficiency?
"For Octus, smart energy works based on our ability to generate significant
energy cost savings, while improving the quality of our clients' facilities,
optimizing their operational savings, capitalizing available rebates and
incentives, and reducing maintenance costs," said Soderquist. "Through the
SmartEnergyWorks blog, we can converse and convene with decision-makers who see
the immediate and perpetual value of investing in energy efficiency."
About Octus Octus, Inc. (OTCBB: OCTI) is a smart energy management company that
reduces energy costs for commercial and institutional building by 50% or more
through energy-efficient lighting, HVAC and ener gy management systems. Octus
makes buildings smart and efficient through its proprietary Smart Energy
Platform (OctusSEP) -- a portfolio of smart devices, sensors, network appliances
and software-enabled energy management services. The company's energy management
software, Octus SmartPortal, enables building owners and managers to command,
control and monitor energy use in real time, from any device. In addition, the
company develops energy projects through the implementation and financing of
energy-efficient lighting, mechanical and energy management measures. Octus was
founded in 1983 and is headquartered in Davis, California.
Contact:
Chris Soderquist
Octus
Email Contact
530/564-0200
http://octusenergy.com
SOURCE: Octus, Inc.
CONTACT: http://www2.marketwire.com/mw/emailprcntct?id=8E29B2FF9A 5BA49B
http://octusenergy.com/
Copyright 2010 Marketwire, Inc., All rights reserved.
-0-
SUBJECT CODE: Energy and Utilities:Utilities
Energy and Utilities:Alternative Energy
I keep an old Scottrade account active because their news alert service is the fastest I have found and it's free.
I liked the read, too!
TDGI NEWS --
NEW YORK, May 19, 2010 (BUSINESS WIRE) -- Encouraged by support from film
critics and major theatre chains, four upcoming theatrical titles from Hannover
House will see a significant expansion of their rel ease plans, reports C.E.O.
Eric Parkinson.
"Racing Dreams," the acclaimed, award-winning documentary from Academy Award
nominated director Marshall Curry premiered last night in Charlotte, NC to an
enthusiastic, standing-room-only audience at the EpiCentre Theatre, followed by
a Best Buy sponsored reception at the new, $200-million dollar NASCAR Hall of
Fame. Hannover's original theatrical plans for the film called for a limited
release in 4 key markets. However, following the film's screening to theatre
chains at ShoWest, Hannover expanded the release to 35 prints in 11 markets
beginning this Friday. By June 18, the Hannover expansion should reach over 150
theaters in 45 markets nationwide.
"It's turning into a much larger release than any of us anticipated," said
Parkinson. "There's so much enthusiasm that some theatres will be holding
midnight screenings on Thursday night to get a jump start on the weekend."
Other thea trical titles from Hannover House, including Joel Schumacher's
star-studded "Twelve," as well as the Sundance Audience Award Winner,
"HappyThankYouMorePlease" and the action-adventure, "The Wild Hunt," will also
benefit from expanded theatrical release plans.
"The exhibitors are responding very positively to our titles," continued
Parkinson. "The quality is there, and the marketing support materials are
proving to be extremely effective. We plan to make the most of the summer
theatrical market, to maximize our box office performance and to set the stage
for strong revenues from video and ancillary income streams."
In addition to the four, previously announced theatrical titles, Hannover House
will be announcing two new releases for this fall, and is currently seeking
additional acquisitions at the Cannes Film Festival. The expanded release plans
and additional new titles are expected to accelerate Hannover's revenues and
growth during 2010.
Corporately, parent company Target Development Group, Inc. is exploring
opportunities that could accelerate the company's move off the Pinksheets and
onto the Bulletin Board or American Stock Exchange. A 2009 year-end audit is
underway with Hogan Taylor, LLP, the completion for which will open new
corporate options, including beneficial merger structures.
"Our 3-to-5 year plan now seems obtainable in only 1-to-3 years," said
Parkinson.
Hannover House is the entertainment and media distribution division of Target
Development Group, Inc. (Pinksheets: TDGI) (Other: www.HannoverHouse.com)
SAFE HARBOR STATEMENT
This press release may contain certain forward-looking statements within the
meaning of Sections 27A & 21E of the amended Securities and Exchange Acts of
1933-34, which are intended to be covered by the safe harbors created thereby.
Although the company believes that the assumptions underlying theforward-looking statements contained herein are reasonable, there can be no
assurance that these statements included in this press release will prove
accurate.
SOURCE: Hannover House
CONTACT:
Hannover House
Susannah Patton, Director of Marketing & Publicity
479-751-4500
Susannah@HannoverHouse.com
Copyright Business Wire 2010
-0-
KEYWORD: United States
North America
New York
INDUSTRY KEYWORD: Motor Sports
Entertainment
Film & Motion Pictures
Sports
SUBJECT CODE: Product/Service
TDGI NEWS --
NEW YORK, May 19, 2010 (BUSINESS WIRE) -- Encouraged by support from film
critics and major theatre chains, four upcoming theatrical titles from Hannover
House will see a significant expansion of their rel ease plans, reports C.E.O.
Eric Parkinson.
"Racing Dreams," the acclaimed, award-winning documentary from Academy Award
nominated director Marshall Curry premiered last night in Charlotte, NC to an
enthusiastic, standing-room-only audience at the EpiCentre Theatre, followed by
a Best Buy sponsored reception at the new, $200-million dollar NASCAR Hall of
Fame. Hannover's original theatrical plans for the film called for a limited
release in 4 key markets. However, following the film's screening to theatre
chains at ShoWest, Hannover expanded the release to 35 prints in 11 markets
beginning this Friday. By June 18, the Hannover expansion should reach over 150
theaters in 45 markets nationwide.
"It's turning into a much larger release than any of us anticipated," said
Parkinson. "There's so much enthusiasm that some theatres will be holding
midnight screenings on Thursday night to get a jump start on the weekend."
Other thea trical titles from Hannover House, including Joel Schumacher's
star-studded "Twelve," as well as the Sundance Audience Award Winner,
"HappyThankYouMorePlease" and the action-adventure, "The Wild Hunt," will also
benefit from expanded theatrical release plans.
"The exhibitors are responding very positively to our titles," continued
Parkinson. "The quality is there, and the marketing support materials are
proving to be extremely effective. We plan to make the most of the summer
theatrical market, to maximize our box office performance and to set the stage
for strong revenues from video and ancillary income streams."
In addition to the four, previously announced theatrical titles, Hannover House
will be announcing two new releases for this fall, and is currently seeking
additional acquisitions at the Cannes Film Festival. The expanded release plans
and additional new titles are expected to accelerate Hannover's revenues and
growth during 2010.
Corporately, parent company Target Development Group, Inc. is exploring
opportunities that could accelerate the company's move off the Pinksheets and
onto the Bulletin Board or American Stock Exchange. A 2009 year-end audit is
underway with Hogan Taylor, LLP, the completion for which will open new
corporate options, including beneficial merger structures.
"Our 3-to-5 year plan now seems obtainable in only 1-to-3 years," said
Parkinson.
Hannover House is the entertainment and media distribution division of Target
Development Group, Inc. (Pinksheets: TDGI) (Other: www.HannoverHouse.com)
SAFE HARBOR STATEMENT
This press release may contain certain forward-looking statements within the
meaning of Sections 27A & 21E of the amended Securities and Exchange Acts of
1933-34, which are intended to be covered by the safe harbors created thereby.
Although the company believes that the assumptions underlying theforward-looking statements contained herein are reasonable, there can be no
assurance that these statements included in this press release will prove
accurate.
SOURCE: Hannover House
CONTACT:
Hannover House
Susannah Patton, Director of Marketing & Publicity
479-751-4500
Susannah@HannoverHouse.com
Copyright Business Wire 2010
-0-
KEYWORD: United States
North America
New York
INDUSTRY KEYWORD: Motor Sports
Entertainment
Film & Motion Pictures
Sports
SUBJECT CODE: Product/Service
CYPW NEWS --
POMPANO BEACH, Fla., May 18, 2010 (BUSINESS WIRE) -- Cyclone Power Technologies
(Pink Sheets: CYPW) has filed with the OTC Markets its Quarterly Report for the
period ended March 3 1, 2010, and has released the following letter to
shareholders:
May 17, 2010
Dear Friends of Cyclone,
Greetings from South Florida! I would like to share with you some of the
financial and operational highlights from the first three months of 2010, as
detailed in our Quarterly Report filed with the OTC Markets.
Financial Development
In the first three months of 2010, we generated $104,900 of revenue compared to
$44,938 for the same period in 2009, an increase of 133% primarily due to the
delivery in March 2010 of our biomass-to-power engine system to Robotic
Technologies under a U.S. Department of Defense sponsored project.
We incurred operating expenses for the first quarter of 2010 of $434,837 as
compared to $417,424 for the same period in 2009. This increase is primarily due
to having more engineers on staff as we grow our operations, and paying higher
professional services in connection with the filing of audited financial
statements with our 2009 Annual Report. Partially offsetting these expenses in
2010 were reduced R&D costs of $91,316 (39%), which reflects in part the
assignment of resources from research to the production of deliverable inventory
as certain of our engine prototypes near completion. Overall, however, net loss
for the recent quarter was $393,901 as compared to a net loss of $402,948 for
the same period in 2009.
We ended the first quarter with cash of $123,000 and total current assets of
$365,000. In the period, we sold 1,303,905 shares of common stock for $115,211,
19,000 shares of Series A Preferred Stock for $95,000, and issued for services
869,200 shares of restricted common stock and 450,000 common stock options
valued at $89,722. As we have said before, we believe that the continued
interest among our key employees and contractors to receive stock and stock
options in lieu of some or all of their cash comp ensation demonstrates an
unwavering commitment to the completion of our technological development and the
success of our company.
Since the end of the first quarter, we have strengthened our cash position by
over $285,000 through the sale of approximately 48,000 additional shares of
Series A Preferred Stock and receipt of $44,900 in design, consulting and
testing fees, partially from continued services performed for Raytheon Company.
You can find our full financial statements with footnotes in our Quarterly
Report for the period ended March 31, 2010, filed with www.otcmarkets.com.
Engine Projects and Technological Development
Waste Energy Recovery: In the first quarter of 2010, we strengthened our
commitment to the technological and strategic development of the waste energy
recovery side of our business. We see the use of waste energy resources such as
used motor oils and exhausted heat from industrial processes to run o ur engines
as representing a greatly underserved market with incredible importance for the
future of our nation's energy policy and our planet's environmental
sustainability. The U.S. Department of Energy has estimated that the efficient
recycling of energy such as used oil and waste heat over the next 20 years can
help reduce our national dependence on petroleum imports, spark billions of
dollars in private investments, and create up to one million jobs in the U.S.
In connection with these opportunities, we continue to advance the development
of our Mark V engine for use with waste oil fuels. This project is being funded
by Phoenix Power Group under our license signed with them in mid-2009. Phoenix
has also recently brought to the table Clean Burn Energy Systems, which is the
leading manufacturer and distributor of waste oil heaters in the world. Working
together on development, marketing, sales and installations, we see huge
poten tial for Cyclone Engines to be the power source for electric generators
running on waste oil fuels, which the EPA considers an important renewable
energy source.
In April we completed the baseline Waste Heat Engine (WHE-25) to be delivered to
Bent Glass Design, Inc. of Hatboro, PA -- which will power a system that will
produce up to 10kW of electricity from the heat exhausted from their furnaces.
We are now testing a newly-designed heat exchanger that will more efficiently
convert heat from their exhaust stacks to our engines' working fluid. We are
also in discussions with several other beta sites to test our waste heat
recovery systems once our initial unit is installed at Bent Glass. We will
conduct these projects through our subsidiary company, Cyclone-WHE LLC, which
was formed with the expectation of generating revenue from the sale and
installation of complete waste heat recovery systems (i.e., not through
licensing revenue, as is Cyclone's business model).
Military: In the first quarter of 2010, we delivered our biomass-to-power system
to our client Robotic Technology Inc., which commissioned the system pursuant to
its Phase II SBIR project sponsored by the Defense Advanced Research Projects
Agency (DARPA), an agency of the U.S. Department of Defense. RTI is building the
EATR, an autonomous robotic platform for long-range reconnaissance; however, we
believe that there are vast commercial opportunities for Cyclone's
biomass-to-power system beyond military purposes. We also continued to perform
testing and design services for Raytheon Integrated Defense Systems, a business
of Raytheon Company, and we are in discussions with them regarding the next
phases of a collaborative project slated for late 2010.
Solar: Our solar thermal engine being developed for Renovalia Energy is
progressing well and performance testing has commenced as of the date of this
le tter. We expect to provide results and pre-production design drawings to our
licensee shortly.
Land Steam Record: As development of our Mark V engine progresses, so does our
project with the U.S. Land Steam Record team, which plans to use this engine to
power the fastest steam vehicle on earth. If you have not already seen it,
please check out the story that the Discovery Channel recently featured on this
project, which has already attracted some interesting contacts and potential
sponsors (Daily Planet, Ep. 168, May 11, 2010).
The first quarter of 2010 was a great start as we strive to advance our
technological development, register our common stock with the Securities
Exchange Commission, and close major agreements with partners like Raytheon. We
are very thankful for your support along this journey, and are confident that
together we can build a company that will make a meaningful impact on our world.
Sincerely, Harry Sch oell, CEO & Director
CORPORATE PROFILE
Cyclone Power Technologies is the developer of the award-winning Cyclone Engine
-- an eco-friendly external combustion engine with the power and versatility to
run everything from portable electric generators and garden equipment to cars,
trucks and locomotives. Invented by company founder and CEO Harry Schoell, the
patented Cyclone Engine is a modern day steam engine, ingeniously designed to
achieve high thermal efficiencies through a compact heat-regenerative process,
and to run on virtually any fuel - including bio-diesels, syngas or solar -
while emitting fewer greenhouse gases and irritating pollutants into the air.
Currently in its late stages of development, the Cyclone Engine was recognized
by Popular Science Magazine as the Invention of the Year for 2008, and was
presented with the Society of Automotive Engineers' AEI Tech Award in 2006 and
2008. Additionally, Cyclone was recently named Environmental Business of the
Year by the Broward County Environmental Protection Department. For more
information, visit www.cyclonepower.com.
Safe Harbor Statement
Certain statements in this news release may contain forward-looking information
within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6
under the Securities Exchange Act of 1934, and are subject to the safe harbor
created by those rules. All statements, other than statements of fact, included
in this release, including, without limitation, statements regarding potential
future plans and objectives of the company, are forward-looking statements that
involve risks and uncertainties. There can be no assurance that such statements
will prove to be accurate and actual results and future events could differ
materially from those anticipated in such statements. The company cautions that
these forward-looking statements are further qualified by o ther factors. The
company undertakes no obligation to publicly update or revise any statements in
this release, whether as a result of new information, future events or
otherwise.
SOURCE: Cyclone Power Technologies
CONTACT:
Cyclone Power Technologies
Media Contact:
Will Wellons, 407-462-2718
will@redletterpr.com
or
Company Contact:
Frankie Fruge, 954-943-8721
Frankie@cyclonepower.com
Copyright Business Wire 2010
-0-
KEYWORD: United States
North America
Florida
INDUSTRY KEYWORD: Energy
& nbsp; Alternative Energy
Oil/Gas
Other Energy
Technology
Other Technology
Transport
Air
Maritime
&nb sp; Rail
Trucking
Other Transport
Public Transport
Manufacturing
Automotive Manufacturing
Environment
; Defense
Other Defense
SUBJECT CODE: Letter
OCTI NEWS --
DAVIS, CA, May 18, 2010 (MARKETWIRE via COMTEX) -- Octus, Inc. (OTCBB: OCTI), a
leading smart energy efficiency company, today announced the signing of a
definitive agreement to acquire privately held Qu antum Energy Solutions, Inc., a
pioneer in energy efficiency project development and smart energy product
commercialization.
"Quantum and its principals are energy industry leaders with a rich history of
successfully deploying energy efficiency projects throughout the United States
and Canada," said Chris Soderquist, Octus CEO. "When the transaction is
completed, we believe the fusion of our companies, our capabilities, and our
sales pipelines will significantly and immediately expand Octus's ability to
develop energy efficiency projects. This will be a seminal step in Octus's
growth as a leading developer of smart energy efficiency solutions."
Founded in 1974, Quantum was one of the first energy management companies in the
United States to specialize in energy efficiency. Quantum's principals have
executed more than 1,500 energy projects totaling more than $100 million in
value for clients including ARCO, Bank of America, Block buster, Chevron, Delta
Airlines, Frito Lay, Hewlett-Packard, Home Depot, Ikea, Nabisco, Pepsi, Petco,
Safeway, Sears, Siemens, and University of California.
"Over the past three decades Quantum has helped evolve the energy-efficiency
industry," said Quantum President Jim Collins. "Octus's project development
approach -- including integration of innovative energy efficiency technologies
and organization of creative project financing -- fills an unmet and rapidly
expanding opportunity in the commercial building market space. In addition, we
look forward to marketing the Octus Smart Energy Platform to Quantum's client
base. The time to act is now, and together we are well poised to capitalize
opportunities."
About Octus Octus, Inc. (OTCBB: OCTI) is a smart energy management company that
reduces energy costs for commercial and institutional building by 50% or more
through energy-efficient lighting, HVAC and energy management systems . Octus
makes buildings smart and efficient through its proprietary Smart Energy
Platform (OctusSEP) -- a portfolio of smart devices, sensors, network appliances
and software-enabled energy management services. The company's energy management
software, Octus SmartPortal, enables building owners and managers to command,
control and monitor energy use in real time, from any device. In addition, the
company develops energy projects through the implementation and financing of
energy-efficient lighting, mechanical and energy management measures. Octus was
founded in 1983 and is headquartered in Davis, California.
Forward-Looking Statements This press release contains forward-looking
statements, including, without limitation, statements as to financial
projections and management's beliefs, expectations, goals and opinions. The
company does not undertake to update or revise these statements, which are based
on a number of assumptions conce rning future conditions that may ultimately
prove to be inaccurate. Future events and their effects on the company may not
be those anticipated, and actual results may differ materially from the results
anticipated in these forward-looking statements. The risks, uncertainties and
factors that could cause or contribute to such material differences are
discussed in the company's annual report on Form 10-K for the year ended
December 31, 2009, filed by the company with the Securities and Exchange
Commission, as updated or supplemented from time to time in subsequent filings.
In addition, this press release contains a number of forward-looking statements
concerning anticipated operations for 2010. The company has only recently become
engaged in the smart energy business and does not have a history of operations
on which future results can be based.
Contact:
Chris Soderquist
Octus
Email Contact
5 30/564-0200
http://octusenergy.com
SOURCE: Octus, Inc.
CONTACT: http://www2.marketwire.com/mw/emailprcntct?id=2B63B9DD2DDF045E
http://octusenergy.com/
Copyright 2010 Marketwire, Inc., All rights reserved.
-0-
SUBJECT CODE: Energy and Utilities:Alternative Energy
Energy and Utilities:Utilities
Energy and Utilities:Equipment
MMRF NEWS --
LOS ANGELES, CA, May 17, 2010 (MARKETWIRE via COMTEX) -- MMR Information
Systems, Inc. (OTCBB: MMRF)
Dear Stockholder:
Today we filed our quarterly statement for the three months ended March 31,
2010. I wan ted to take this opportunity to discuss the filing and give you
insight into our plans to generate revenue as we evolve into MMRGlobal.
We are well on our way towards achieving a global footprint from which we will
sell our proprietary line of Personal Health Record and Professional Medical
Record products and services.
Following my recent travels to China and South Africa to meet with the Chartis
groups, I immediately flew to Washington, D.C., where MMR Advisor, former House
Majority Leader, the Hon. Richard A. "Dick" Gephardt, and MMR Director, the Hon.
Hector V. Barreto, were instrumental in arranging meetings with Senators,
Congress Members and government healthcare officials including Dr. David
Blumenthal, National Coordinator for Health Information Technology, as well as
investors and potential strategic partners to demonstrate our cost-saving and
unique technologies.
At the invitation of Mr. Barreto, who serves as Cha irman of The Latino
Coalition, I also introduced onstage our strategic partner, Kodak, as the new
sponsor of the Coalition. Latino economic consumption is estimated to be nearing
a trillion dollars annually, and we expect to be able to sell our Personal
Health Record products directly into this market in conjunction with Kodak
through the Coalition.
I was particularly pleased to talk at some length with former House Speaker Newt
Gingrich, one of the nation's leading proponents of healthcare reform, and
update him on the progress of MMR since we last met approximately three years
ago.
Although we incurred a net loss of $6.5 million during the first quarter, $5.3
million of that loss represents non-cash expenses driven by $4.2 million from
the application of accounting principles to value derivative liabilities and
equity as well as an additional $1.0 million from stock options, warrants and
common stock issued for services.
Although we disclosed an accounts payable balance of $3.0 million, $2.5 million
of that balance is attributable to the reverse merger with Favrille and only
$389 thousand represents MMR trade payables. Accordingly, we maintain good
relationships with its vendors. In 2009, we were able to issue equity in lieu of
cash to reduce liabilities by $920 thousand which included $290 thousand towards
a reduction in accounts payable. We plan on using our increasing stock value to
further reduce liabilities and strengthen our balance sheet.
Our ability to issue equity for services has allowed us to accumulate $878
thousand in cash which we will use to support sales of MMRPro while continuing
to enhance product functionality and to exploit our biotech assets, patents and
other operating expenses.
In addition, since the end of the first quarter our filing discloses subsequent
events that have eliminated derivative liabilities in the amount of $3.7
million, or 36.1% which also will continue to improve our balance sheet
position.
We will continue to take advantage of our stock value to improve our balance
sheet and attract strategic partners and employees, consultants and management.
We also plan on using our equity for Merger and Acquisition opportunities,
including some currently under preliminary evaluation. All of these actions can
contribute to an increase in our value for the benefit of stockholders.
Although our financial condition remains largely static as compared to a year
ago, as a result of our efforts, we now are positioned to take advantage of
multiple income streams that did not exist then.
During the first quarter we began the process of selling and installing the
first group of 10 MMRPro systems in physician offices. The installation and
sales implementation process takes approximately 6 to 10 weeks. This encompasses
a checklist of more than 50 items which includes everything from where the
system hardware will be located, connected and installed, a detailed analysis of
office workflow, and customizing connectivity to any existing office practice
management system. These initial installations are being handled by us on a
direct basis. However, we receive substantial installation support from Kodak
and selected Kodak resellers.
Starting in the third quarter we will be calling on physician offices throughout
the United States through the nationwide Kodak reseller channel.
We also plan on building strategic relationships with hospitals to underwrite
the use of MMRPro for staff physicians. This could enable staff physicians to
digitize patient charts prior to admissions, streamlining the admissions process
for the patients to the hospital.
In addition to its product functionality, MMRPro includes a "Stimulus Program"
for healthcare professionals that creates a reven ue opportunity for physicians
from patient upgrades. We believe that our Stimulus Program can generate at
least as much money for the average group practice over a three year term as the
$44,000 that is possible through the HITECH Act over a five year period.
We retained Global Research Services LLC, a full-service clinical trials
management organization, to assist us in our efforts to accelerate bringing to
market its anti-CD20 monoclonal antibodies. Anti-CD20 antibodies are useful in
treating B-Cell malignancies, including Non-Hodgkin's Lymphoma (NHL) and
additional B-Cell mediated conditions such as rheumatoid arthritis. Global
Research Services specializes in serving sponsors of Phase I-IV research. MMR's
anti-CD20 antibody asset is potentially a candidate for the next generation
Rituximab, marketed under the trade name Rituxan(R) in the United States by
Biogen Idec and Genentech (wholly owned member of the Roche Group) and under t he
name MabThera(R) by Roche in the rest of the world except Japan, where it is
co-marketed by Chugai and Zenyaku Kogyo Co. Ltd. Rituxan/MabThera is one of the
world's most successful monoclonal antibodies with reported total sales in 2009
in excess of US$5.6 billion.
Beginning in June 2009, we filed various national phase filings from the Patent
Cooperation Treaty patent application directed to the anti-CD20 monoclonal
antibodies, including in the United States, Australia, Brazil, Canada, China,
Europe, India, Japan, South Korea and Mexico.
We also acquired certain intellectual property rights involving B and T cell
vaccine technology relating to the FavID vaccine in various stages in the United
States and foreign countries through its reverse merger with Favrille. We are
also in the process of filing certain patents regarding numerous aspects of the
FavID vaccine. We cannot guarantee the status or issuance of any patents andpatent applications. However, we are acting to pursue and maintain available
intellectual property protection relating to the FavID vaccine and intellectual
property portfolio in the United States and major foreign markets of interest.
We are also in the process of adding experienced venture capitalists to our
Medical Board of Advisers to assist us in generating revenue through licensing
agreements and milestone payments from our biotech assets and other intellectual
property, which we acquired from the reverse merger with Favrille. The assets
include, but are not limited to, data from our pre-merger clinical vaccine
trials, the Specifid vaccine, and the anti-CD20 antibodies. Given recent
developments with Dendreon and the similarities to our manufacturing process and
the drug Provenge, we will continue to explore any opportunities to resurrect
and or take advantage of any pre-merger assets.
As we previously disclosed, on March 2 2, 2010, we entered into a Master Services
Agreement with Chartis International LLC ("Chartis"). Chartis provides a wide
range of insurance solutions and is one of the world's leading property-casualty
and general insurance organizations, with operations in over 160 countries and
jurisdictions. We plan on providing MMR's secure online Personal Health Record
products to Chartis policyholders worldwide starting prior to the end of this
year. Initially, translations of our products are first expected to be available
in English, Spanish, French, German, Italian, Japanese and Chinese.
We are also in active negotiations with a major financial institution regarding
the development of paperless loan processing and delivery solutions whereby loan
documents can be delivered electronically through our MyESafeDepositBox product,
with resultant completed documents being filed in a permanent online
MyESafeDepositBox account.
At the first of t he year, we entered into a Cooperation Agreement with
Unis-Tonghe Technology Co. ("Unis"). Under the Cooperation Agreement we and Unis
agreed to form a joint venture in China for the purpose of deploying our
personal health record services and document imaging and management solutions in
China for use in the Chinese Government's comprehensive electronic medical
records system. If and when the joint venture is approved by the Chinese
government, Unis will own 60% and MMR will own 40%. Meanwhile we have begun to
leverage our resources in China with other U.S. partners, including Kodak. As a
result, we anticipate selling MMRPro through Kodak resellers throughout the Asia
Pacific region in advance of a Unis MMR EMR product launch. We also believe that
China will provide one of the earlier Chartis revenue streams.
We were recently profiled in the May edition of PharmaVOICE magazine regarding
its products and the value to the Clinical Trials market and big Pharma. We
believe we can generate revenues by using our PHR to connect patients to
Clinical Trials through existing strategic partnerships and agreements. We will
also offer customized tools for the Clinical Trials marketplace and plan on
having them introduced starting at the Drug Information Association's Annual
Meeting in Washington, D.C. June 13 to 17, 2010.
I also want to inform you of the possibility we may enter into an agreement for
a standby line of credit, which will be available to us as we continue to
globally expand our proprietary suite of electronic health records products. I
will convey this to you immediately should we take this step, but we have made
no decision as of yet as to whether to enter into such agreement.
Many of you have expressed concern about how we will finance ourselves going
forward and the dilutive impact on our equity. Simply put, it takes money to
make money. Last July, our s tockholders approved an increase of our authorized
Common Stock from 150 million shares to 650 million shares. Since that time, we
have issued less than 10% of the total outstanding in additional shares; yet,
our value has more than doubled. Accordingly, we are still considering all
options to finance growth.
We will need to continue to meet obligations necessary to finance our growth
internationally. As always, as new developments occur, I will disclose them in a
timely manner.
One of the best ways to understand the value of your company is by using its
products and services. Therefore, if you have not already done so, please take
some time over the upcoming Memorial Day holiday to reach out to your family and
friends and set up a MyMedicalRecords.com or MyESafeDepositBox.com account. You
will appreciate the safety and security of having all your important documents
and medical records securely stored online in the event of an emergency, and
you'll be proud to be an owner of MMR and our potentially lifesaving products.
Thank you for your continued support of MMR.
Sincerely,
Robert H. Lorsch Chairman, President & Chief Executive Officer
About MMR Information Systems, Inc.
MMR Information Systems, Inc., through its wholly-owned operating subsidiary,
MyMedicalRecords, Inc. ("MMR"), provides secure and easy-to-use online Personal
Health Records ("PHRs") and electronic safe deposit box storage solutions,
serving consumers, healthcare professionals, employers, insurance companies,
unions and professional organizations and affinity groups. MyMedicalRecords
enables individuals and families to access their medical records and other
important documents, such as birth certificates, passports, insurance policies
and wills, anytime from anywhere using the Internet. The MyMedicalRecords
Personal Health Record is built on proprietary, patented technologie s to allow
documents, images and voicemail messages to be transmitted and stored in the
system using a variety of methods, including fax, phone, or file upload without
relying on any specific electronic medical record platform to populate a user's
account. The Company's professional offering, MMRPro, is designed to give
physicians' offices an easy and cost-effective solution to digitizing
paper-based medical records and sharing them with patients in real time. MMR is
an Independent Software Vendor Partner with Kodak to deliver an integrated
turnkey EMR solution for healthcare professionals. MMR is also an integrated
service provider on Google Health. To learn more about MMR Information Systems,
Inc. and its products, visit www.mymedicalrecords.com and view the videos at
www.mymedicalrecordsonline.com/videos.
Forward-Looking Statements Any statements contained in this press release that
refer to future events or other non-historical matters are forward-looking
statements, and some can be identified by the use of words (and their
derivations) such as "need," "possibility," "offer," "development," "if,"
"negotiate," "when," "begun," "believe," "achieve," "will," "estimate,"
"expect," "maintain," "plan," and "continue." MMR Information Systems, Inc.
disclaims any intent or obligation to revise or update any forward-looking
statements. These forward-looking statements are based on MMR Information
Systems, Inc.'s reasonable expectations as of the date of this press release and
are subject to risks and uncertainties that could cause actual results to differ
materially from current expectations. The information discussed in this release
is subject to various risks and uncertainties related to changes in MMR
Information Systems, Inc.'s business prospects, results of operations or
financial condition, government regulation, and such other risks and
uncertainties as detailed from time to time in MMR Information Systems, Inc.'s
public filings with the U.S. Securities and Exchange Commission.
CONTACT:
Bobbie Volman
MMR Information Systems, Inc.
(310) 476-7002, Ext. 2005
bvolman@mmrmail.com
Michael Selsman
Public Communications Co.
(310) 553-5732
ms@publiccommunications.biz
SOURCE: MMR Information Systems, Inc.
CONTACT: mailto:bvolman@mmrmail.com
mailto:ms@publiccommunications.biz
Copyright 2010 Marketwire, Inc., All rights reserved.
-0-
SUBJECT CODE: Computers and Software:Internet
& nbsp; Medical and Healthcare:Healthcare
Financial Services:Insurance
Computers and Software:Software
SIVC NEWS --
DANVILLE, Calif., May 17, 2010 (GlobeNewswire via COMTEX) -- S3 Investment
Company, Inc. (PinkSheet s:SIVC) today announced the signing of a new client for
its wholly owned Redwood Capital subsidiary, which acts as the Chinese merchant
banking advisor to its client as they pursue public listings and additional
financing in the North American capital markets. The new client is a retail
drugstore operator and medicine wholesale operator in western China.
Redwood Capital's new client has an integrated business chain ranging from
medicine manufacturing to medicine distribution to retail sale, with a
well-built brand name. The client's core product has ranked No.1 for several
years in China in its category of products and has a well-built market network
with more than 1,500 directly operated or franchised drugstores in just one
province. It has exclusive supply rights to products for over 1,800 healthcare
and medical institutions and distribution rights to healthcare and medical
institutions in one major and several secondary cities. The company,
headquartered in a superior geographic location with one of the largest drug
materials bases in China, also has highly experienced management and
professionals.
As a country with one fourth of the world population, the pharmaceutical
industry is an extremely important sector of China's national economy. With the
increasing demand in domestic market, China possesses one of the most rapidly
developing pharmaceutical markets in the world.
S3 expects to provide additional information about this client in future news
releases.
"We are pleased to announce another new Redwood Capital client and look forward
to the opportunity to bring this company to the North American capital markets,"
said S3 Investment Company Chairman and CEO Jim Bickel. "Redwood Capital's
management team continues to identify, conduct due diligence on, and bring under
contract high quality client companies that are judged to have significant
pot ential as public companies, and this new client is no exception. The
pharmaceutical market in China is large, and all signs point to higher rates of
growth as the demand for quality healthcare for a growing middle class increases
in most areas of the country."
S3 Investment Company also recently posted its Company Information and
Disclosure Statement for the period ended March 31, 2010 at www.otcmarkets.com.
The filing, which reports the value of the stock payments that Redwood Capital
receives from its clients' transactions, will allow S3 to maintain its "Current
Information" status at the OTC Markets site.
To sign up to receive information by email directly from S3 Investment Company
when new press releases, investor newsletters, SEC filings or other information
is disclosed, please visit http://www.s3investments.com/investors/.
About S3 Investment Company, Inc.
S3 Investment Company, Inc. (http://www.s3investments.com ) and its Redwood Group
International subsidiary are focused on facilitating the success of two
subsidiaries operating in the China market. Redwood Capital, Inc. assists
private Chinese companies in accessing the North American capital markets by
utilizing a network of investment banking relationships to achieve reverse
merger transactions. For more information, please visit
http://www.redwoodcapinc.com. Redwood Medical, Inc. assists companies seeking to
import and distribute Western medical technologies and products into the China
market.
Any statements contained herein related to future events are forward-looking
statements and are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. Readers are cautioned not to place
undue reliance on forward-looking statements. S3 Investment Company, Inc.
undertakes no obligation to update any such statements to reflect actual events.
This n ews release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: S3 Investment Company, Inc.
By Staff
CONTACT: CONTACT: S3 Investment Company
Investor Relations
888-528-0883
investors@s3investments.com
(C) Copyright 2010 GlobeNewswire, Inc. All rights reserved.
-0-
INDUSTRY KEYWORD: Business Services
SUBJECT CODE: BANKING
CORPORATE
Company Announcement
This is good, this is very good. ;)
DYER .036 up 100% today. Meuse shell that could be a good one.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=49970144
that's what I'm thinkin' as well.